First-in-human phase 1 study of filanesib (ARRY-520), a kinesin spindle protein inhibitor, in patients with advanced solid tumors. (Q53607758)
Jump to navigation
Jump to search
scientific article
Language | Label | Description | Also known as |
---|---|---|---|
English | First-in-human phase 1 study of filanesib (ARRY-520), a kinesin spindle protein inhibitor, in patients with advanced solid tumors. |
scientific article |
Statements
First-in-human phase 1 study of filanesib (ARRY-520), a kinesin spindle protein inhibitor, in patients with advanced solid tumors. (English)
Patricia M LoRusso
Priscila H Goncalves
Lindsay Casetta
Judith A Carter
Kevin Litwiler
Dale Roseberry
Selena Rush
Jennifer Schreiber
Heidi M Simmons
Mieke Ptaszynski
Edward A Sausville
17 February 2015
33
2
440-449
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference